There were no major associations between cfDNA concentration/integrity and gender, age, TNM stage, tumor location, NSE, and AFP expression within the patients' pre/postchemotherapy CRC cohort, all at P > 0.05. This evidence concerns the gene ENO2 and colorectal carcinoma.